Fidelity's passive stake at 5.2% is unchanged from prior levels, indicating no material conviction shift. Monitor for any future conversion to a 13D filing, which would signal activist intent.
ASND drugs
ASND drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $253.45entry
- T+1 · 11d ago +1.33%α +1.02% · $256.82
- T+5 · 5d ago +5.37%α +2.08% · $267.07
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 3,425,993 shares of Ascendis Pharma A/S common stock as of September 30, 2026, representing 5.2% of shares outstanding. This is a routine passive stake update with no change in the percentage from the prior filing period, indicating Fidelity maintained its position.
Key Financial Metrics
Key Facts
- FMR LLC reported beneficial ownership of 3,425,993 shares of Ascendis Pharma A/S common stock as of September 30, 2026.
- The stake represents 5.2% of the total outstanding common stock.
- The filing is an amendment to Schedule 13G, indicating passive investment intent under Rule 13d-1(b).
- Abigail P. Johnson is also reported as a beneficial owner of the same 3,425,993 shares (5.2%) due to her control of FMR LLC.
- The filing includes a joint filing agreement among FMR LLC and its subsidiaries.
Financial Impact
Stake valued at approximately $858 million based on $16.5B market cap and 5.2% ownership.
Risk Factors
- No material risks identified from this routine passive stake filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0000315066-26-002678 |
| Document: 0000315066-26-002678-index-headers.html | 0000315066-26-002678 |
| Document: 0000315066-26-002678-index.html | 0000315066-26-002678 |
| Document: 0000315066-26-002678.txt | 0000315066-26-002678 |
Track record
41 reports on ASND
14 of 19 bullish or bearish reports moved the stock their way by T+60. Best: +26.62% at T+20 after the Jun 2, 2026 report. 25 of 27 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $271.96 Now $271.73 −0.08% settles Feb 12
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $275.39 Now $271.73 −1.33% settles Feb 11
- Nov 12, 20264d ago 6-K Bullish 6/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
- Nov 12, 20264d ago Press Release Neutral 5/10 Entry $267.07 Now $271.73 +1.74% settles Feb 10
- Nov 6, 202610d ago 6-K Bullish 6/10 Entry $259.85 Now $271.73 +4.57% settles Feb 5
- Nov 6, 202610d ago Press Release Bullish 6/10 Entry $256.82 Now $271.73 +5.81% settles Feb 4
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $253.45 Now $271.73 +7.21% settles Feb 3
- Nov 2, 202614d ago Institutional Cluster Bullish 4/10 Entry $250.17 Now $271.73 +8.62% settles Feb 1
- Oct 26, 202621d ago 6-K Bullish 5/10 Entry $245.85 Now $271.73 +10.53% settles Jan 25
- Oct 16, 20264w ago 6-K Bullish 7/10 Entry $225.25 Now $271.73 +20.63% settles Jan 13
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers